Skip to content
20-F

Annual Report (Foreign)

VectivBio Holding AG

0000950170-23-013373

← back to feed
Filed
Apr 19, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2022 · Dec 31, 2022 44.13B sh
Shares Diluted FY 2022 · Dec 31, 2021 26.96B sh
Shares Diluted FY 2022 · Dec 31, 2020 9.6B sh
Shares Outstanding FY 2022 · Dec 31, 2022 67.39M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$56.26M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$72.14M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$38.21M
Cash And Equivalents FY 2022 · Dec 31, 2022 $221.42M
Cash And Equivalents FY 2022 · Dec 31, 2021 $102.71M
Cash And Equivalents FY 2022 · Dec 31, 2020 $40.17M
Cash And Equivalents FY 2022 · Dec 31, 2019 $19.81M
Stockholders Equity FY 2022 · Dec 31, 2022 $213.37M
Stockholders Equity FY 2022 · Dec 31, 2021 $116M
Stockholders Equity FY 2022 · Dec 31, 2020 $32.24M
Stockholders Equity FY 2022 · Dec 31, 2019 $9.26M
Current Liabilities FY 2022 · Dec 31, 2022 $24.74M
Current Liabilities FY 2022 · Dec 31, 2021 $17.18M
Current Liabilities FY 2022 · Dec 31, 2020 $34.76M
Total Liabilities FY 2022 · Dec 31, 2022 $39.23M
Total Liabilities FY 2022 · Dec 31, 2021 $20.53M
Total Liabilities FY 2022 · Dec 31, 2020 $38.32M
Current Assets FY 2022 · Dec 31, 2022 $226.21M
Current Assets FY 2022 · Dec 31, 2021 $110.08M
Current Assets FY 2022 · Dec 31, 2020 $47.55M
Total Assets FY 2022 · Dec 31, 2022 $252.6M
Total Assets FY 2022 · Dec 31, 2021 $136.53M
Total Assets FY 2022 · Dec 31, 2020 $70.56M
Eps Diluted FY 2022 · Dec 31, 2022 −$2.12
Eps Diluted FY 2022 · Dec 31, 2021 −$3.23
Eps Diluted FY 2022 · Dec 31, 2020 −$6.24
Eps Basic FY 2022 · Dec 31, 2022 −$2.12
Eps Basic FY 2022 · Dec 31, 2021 −$3.23
Eps Basic FY 2022 · Dec 31, 2020 −$6.24
Rd Expense FY 2022 · Dec 31, 2022 $73.95M
Rd Expense FY 2022 · Dec 31, 2021 $50.18M
Rd Expense FY 2022 · Dec 31, 2020 $43.04M
Operating Income FY 2022 · Dec 31, 2022 −$80.52M
Operating Income FY 2022 · Dec 31, 2021 −$86.72M
Operating Income FY 2022 · Dec 31, 2020 −$57.26M